Balaxi Pharmaceuticals Ltd

NSE: BALAXI · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹22.38
Market cap: ₹123.5 Cr
Revenue (annual): ₹270.2 Cr
Net profit (annual): ₹1.42 Cr
P/E (TTM): 51.0×Sector 47.3×
Promoter holding: 65.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Earnings Call 2 Business Update 2 Board Meeting Date 2 Annual General Meeting 2 Results Correction 1 Price Movement Clarification 1 Other Announcement 1 Management Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 May 2026 23:45 IST NSE

Board Meeting Outcome

Balaxi Pharmaceuticals Board Meeting Outcome

Balaxi Pharmaceuticals re-appointed Akshita Ostwal as Independent Director for a five-year term. The board also re-appointed Siva Rama Krishna & Associates as Internal Auditors.

Execution: 60 months

Read the filing ↗